MARC Record from harvard_bibliographic_metadata

LEADER: 02237cam a22005294a 4500
001 011422693-8
005 20140407145033.0
008 070918s2008 maua 001 0deng
010 $a 2007038583
015 $aGBA818235$2bnb
016 7 $a101316790$2DNLM
016 7 $a014519926$2Uk
020 $a9781591398615 (alk. paper)
020 $a1591398614 (alk. paper)
035 0 $aocn172980077
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dBAKER$dYDXCP$dUKM$dC#P$dBWX
042 $apcc
043 $an-us---
050 00 $aHD9999.B444$bA443 2008
060 10 $aHD9999.B442$bB612s 2008
082 00 $a338.7/6151092$aB$222
100 1 $aBinder, Gordon M.,$d1935-
245 10 $aScience lessons :$bwhat the business of biotech taught me about management /$cGordon Binder, Philip Bashe.
260 $aBoston, Mass. :$bHarvard Business Press,$cc2008.
300 $aviii, 292 p. :$bill. ;$c22 cm.
500 $aIncludes index.
505 0 $aThe start of a start-up -- Amgen goes public -- The business of science meets the science of business -- From IPO to EPO in four months -- EPO on trial -- Partnerships made in heaven-- and that other place -- Red hot summer -- Nuclear winter -- How to build a winning team -- How Amgen kept employees committed -- The value of ethics in business -- My failed retirement.
610 20 $aAmgen Inc.
600 10 $aBinder, Gordon M.,$d1935-
610 20 $aAmgen Inc.$xManagement.
650 0 $aBiotechnology industries$zUnited States$xManagement.
650 0 $aChief executive officers$zUnited States$vBiography.
600 12 $aBinder, Gordon M.,$d1935-
650 12 $aBiotechnology$xeconomics
650 22 $aBiotechnology$xhistory
650 22 $aHistory, 20th Century
650 22 $aIndustry
655 2 $aPersonal Narratives
610 22 $aAmgen Inc.
650 12 $aBiotechnology$xeconomics$vPersonal Narratives.
650 22 $aBiotechnology$xHistory$vPersonal Narratives.
650 22 $aHistory, 20th Century$vPersonal Narratives.
650 22 $aIndustry$vPersonal Narratives.
700 1 $aBashe, Philip.
776 08 $iOnline version:$aBinder, Gordon M., 1935-$tScience lessons.$dBoston, Mass. : Harvard Business Press, ©2008$w(OCoLC)608887975
988 $a20080401
906 $0OCLC